Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
72.86
0.00 (0.00%)
Feb 20, 2026, 1:21 PM EST - Market open
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $10.98 billion as of February 20, 2026. Its market cap has increased by 175.99% in one year.
Market Cap
10.98B
Enterprise Value
9.15B
1-Year Change
175.99%
Ranking
Category
Stock Price
$72.86
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $10.98B, an increase of 989.65%. That is a compound annual growth rate of 52.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 10.98B | 1.01% |
| Dec 31, 2025 | 10.87B | 213.25% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ionis Pharmaceuticals | 13.32B |
| Summit Therapeutics | 12.25B |
| BioMarin Pharmaceutical | 11.88B |
| Exelixis | 11.55B |
| Madrigal Pharmaceuticals | 11.16B |
| Jazz Pharmaceuticals | 10.25B |
| ABIVAX Société Anonyme | 10.15B |
| Axsome Therapeutics | 9.31B |